IRCT20190210042676N32招募中2 期
Evaluating of safety and efficacy of Stylux Voluma dermal filler (Novajen Daru CO) for correction of moderate to severe nasolabial folds”
ovajen Daru0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 21 years 至 65 years（—）
- 性别
- All
入选标准
- •18 -65 years old men and women
- •Moderate to severe nasolabial folds based on Allergan criteria.
- •The opportunity to accompany the visit programs and study process
- •Signing the informed consent form and agree to a 6-month follow-up.
排除标准
- •Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment.
- •Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry
- •Planning to undergo any of these procedures at any time during the study.
研究者
相似试验
招募中
2 期
Evaluating of safety and efficacy of Stylux REDENSITY ® mesogelskin hydration.Changes in skin textureR23.4IRCT20190210042676N31ovajen Daru20
已完成
不适用
Evaluation of the efficacy and safety of luseogliflozin and changes in QOType 2 diabetes mellitusJPRN-UMIN000023035The Institute for Adult Diseases, Asahi Life Foundation64
已完成
4 期
Evaluating Sublingual immunotherapy in allergic RhinoconjunctivitisEar, Nose and ThroatEye DiseasesPACTR201901529431463Faculty of Medicine Zagazig University120
已完成
不适用
A Clinical study for safety and practical use of vaccine device using microneedlesJPRN-UMIN000004180Osaka University, Graduate School of Medicine Department of Dermatology20
已完成
不适用
Evaluation of the safety and efficacy in linagliptin with type 2 diabetic patients receiving hemodialysis therapytype 2 diabetes mellitusJPRN-UMIN000010099Saitama medical University50